United States · FDA National Drug Code directory
Nintedanib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-639_128511d3-f076-4a68-993b-53ad52233ee2
- Product NDC
- 69097-639
- Form
- CAPSULE
- Composition / generic term
- Nintedanib
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260402
- Source listing expiry
- 20271231
Source-listed ingredients
- NINTEDANIB ESYLATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (69097-639-03) · 69097-639-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →